EP 3908254 A1 20211117 - PHARMACEUTICAL COMPOSITIONS COMPRISING (S)-4-(4-(4-(((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-4-YL)OXY)METHYL) BENZYL)PIPERAZIN-1-YL)-3-FLUOROBENZONITRILE AND METHODS OF USING THE SAME
Title (en)
PHARMACEUTICAL COMPOSITIONS COMPRISING (S)-4-(4-(4-(((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-4-YL)OXY)METHYL) BENZYL)PIPERAZIN-1-YL)-3-FLUOROBENZONITRILE AND METHODS OF USING THE SAME
Title (de)
PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT (S)-4-(4-(4-(((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-4-YL)OXY)METHYL) BENZYL)PIPERAZIN-1-YL)-3-FLUOROBENZONITRIL UND VERFAHREN ZU IHRER VERWENDUNG
Title (fr)
COMPOSITIONS PHARMACEUTIQUES COMPRENANT DU (S)-4-(4-(4-(((2-(2,6-DIOXOPIPÉRIDIN-3-YL)-1-OXOISOINDOLIN-4-YL)OXY)MÉTHYL)BENZYL)PIPÉRAZIN-1-YL)-3-FLUOROBENZONITRILE ET LEURS MÉTHODES D'UTILISATION
Publication
Application
Priority
- US 201962790229 P 20190109
- US 2020012649 W 20200108
Abstract (en)
[origin: US2020215061A1] Provided herein are pharmaceutical compositions (e.g., oral dosage formulations) comprising (S)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile, or an enantiomer, mixture of enantiomers, tautomer, isotopolog, or pharmaceutically acceptable salt thereof, and a carrier or diluent. Also provided herein are methods of preparing and methods of using the pharmaceutical compositions.
IPC 8 full level
A61K 9/00 (2006.01); A61K 9/48 (2006.01); A61K 47/26 (2006.01); A61K 47/36 (2006.01); A61P 35/00 (2006.01)
CPC (source: CN EP IL KR US)
A61K 9/0053 (2013.01 - EP IL); A61K 9/4858 (2013.01 - EP IL KR); A61K 9/4866 (2013.01 - EP IL KR); A61K 31/496 (2013.01 - IL KR US); A61K 47/02 (2013.01 - IL US); A61K 47/12 (2013.01 - KR); A61K 47/24 (2013.01 - KR); A61K 47/26 (2013.01 - EP IL KR US); A61K 47/36 (2013.01 - EP IL KR US); A61P 35/00 (2018.01 - CN EP IL KR); C07D 401/04 (2013.01 - CN)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
US 11779580 B2 20231010; US 2020215061 A1 20200709; AU 2020206692 A1 20210729; BR 112021013383 A2 20210914; CA 3126067 A1 20200716; CN 113597301 A 20211102; CN 114409630 A 20220429; CN 114409630 B 20240402; EA 202191904 A1 20211004; EP 3908254 A1 20211117; IL 284665 A 20210831; JP 2022516989 A 20220303; JP 7489989 B2 20240524; KR 20210113290 A 20210915; MX 2021008321 A 20211013; SG 11202107438W A 20210830; US 2024066026 A1 20240229; WO 2020146441 A1 20200716
DOCDB simple family (application)
US 202016737721 A 20200108; AU 2020206692 A 20200108; BR 112021013383 A 20200108; CA 3126067 A 20200108; CN 202080012815 A 20200108; CN 202210010518 A 20200108; EA 202191904 A 20200108; EP 20704118 A 20200108; IL 28466521 A 20210706; JP 2021539972 A 20200108; KR 20217024896 A 20200108; MX 2021008321 A 20200108; SG 11202107438W A 20200108; US 2020012649 W 20200108; US 202318240076 A 20230830